Medication info

Antiprazole Tablets 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOralExpired
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Korea Sintex Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric-coated tablets
Packaging
28 Tablets/PTP [(14 tablets/PTP x 2)]
Approval status
Expired

MFDS item code 201907670 · Approved 2019.11.01

This product's status changed to Expired on 2024.11.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcer disease (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on the symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, if needed, using an on-demand regimen of 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this medicine 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ◯ Elderly patients Administer with caution, as hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Korea Sintex Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcer disease (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers infected with Helicobacter pylori
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers and is used to alleviate symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also suitable for long-term maintenance therapy of gastroesophageal reflux disease and is used in combination with antibiotics for treating gastrointestinal ulcer patients infected with Helicobacter pylori. It helps in treating Zollinger-Ellison syndrome. In short, it is used to improve and treat various gastrointestinal-related diseases.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on the symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not resolved after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, the 20 mg twice-daily dose is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled, if needed, using an on-demand regimen of 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this medicine 20 mg be administered in combination with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Hepatic encephalopathy has been reported as an adverse reaction in patients with cirrhosis. Therefore, administer with caution. ◯ Elderly patients Administer with caution, as hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be administered to patients with hypersensitivity to certain components or benzimidazole derivatives. Caution is required when using in patients allergic to penicillin and macrolide antibiotics, particularly when used in combination for Helicobacter pylori eradication therapy. Cardiac side effects may occur when taken with certain cardiac-related medications, so co-administration should be avoided. It is safer for pregnant or breastfeeding women not to use this medication. Patients with impaired liver function or the elderly should be administered with caution due to the higher risk of side effects. This medication contains Yellow No. 4 dye, so those allergic to this ingredient should use it with caution. If any adverse reactions such as skin rash, hives, or itching occur during use, the medication should be discontinued immediately. Regular hematological tests are required as abnormalities may be detected in blood tests. Liver function tests should also be conducted regularly; if any abnormalities are found, immediate action must be taken. Symptoms related to cardiovascular issues or gastrointestinal symptoms may occur, and consulting with a healthcare provider is advised if any such symptoms arise. Symptoms related to the central nervous system or respiratory symptoms have also been reported, so caution is necessary. Long-term use may increase the risk of fractures related to osteoporosis, and therefore, careful monitoring is required during prolonged therapy. Magnesium levels may decrease, so regular monitoring is necessary when used for extended periods or in combination with certain drugs. Due to inhibition of gastric acid secretion, there may be a slight increase in the risk of gastrointestinal bacterial infections; if diarrhea persists, inform a healthcare provider. Drowsiness or other effects may occur when driving or operating machinery, so caution is required. There may be potential interactions with other medications, so it is essential to consult with a healthcare provider regarding any co-administered drugs. Use during pregnancy is contraindicated, and it is also safer not to use during breastfeeding. Elderly patients may have a higher likelihood of experiencing side effects due to decreased liver function; careful administration is advised in case symptoms occur. Safety in pediatric patients has not been established, and experience with its use is limited. Do not chew or crush the tablets; swallow them whole. Keep out of reach of children and it is advisable not to transfer to another container. Long-term use of this medication may cause vitamin B12 absorption disorders, so regular checks are necessary if required. Autoimmune conditions such as erythema multiforme or systemic lupus erythematosus may develop, so consult a specialist immediately if any unusual symptoms occur. Kidney-related side effects such as acute interstitial nephritis can occur, so discontinue use immediately if any signs of kidney dysfunction appear. There is no specific antidote for overdose; treatment should be symptomatic and supportive.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, increased ALT, increased AST, increased ALP, increased γ-GTP, increased LDH, increased total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, atrioventricular block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, dry mouth, vomiting, lower abdominal pain, gastric atony, gastritis, stomatitis, taste disorder, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, neurogenic hypersensitivity, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased circulatory blood volume, flaccidity of extremities, sensory loss, decreased grip strength, language confusion, staggering, disorientation, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthralgia, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, increased total cholesterol, increased triglycerides, increased BUN, increased serum thyroid stimulating hormone, chest pain, chills, fever, urinary tract infection, lethargy, weight gain, visual disturbances, appetite loss, cervical stiffness, phototoxic reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, increased thyroid stimulating hormone, cutaneous lupus erythematosus, systemic lupus erythematosus, cutaneous lupus erythematosus, systemic lupus erythematosus, cutaneous lupus erythematosus, systemic lupus erythematosus, cutaneous lupus erythematosus, acute interstitial nephritis, lethargy, nausea, appetite loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container as it may be sensitive to air or moisture. It is also advisable to keep it at room temperature between 1 and 30 degrees Celsius to maintain its efficacy for an extended period.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablets

Package unit

28 Tablets/PTP [(14 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.